Editing
Pediatrics: UPJO & Megaureter
(section)
Jump to navigation
Jump to search
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Megaureter == * '''Definition of megaureter: dilatation of the ureter irrespective of cause''' === Classification === *'''Classified as primary vs. secondary''' ** '''Primary obstructed megaureters (POM)''' *** '''A condition intrinsic to the ureter itself;''' '''obstruction results from the presence of an abnormal adynamic segment at the terminal end of the ureter near or at the ureterovesical junction (UVJ)''' **** Insufficient peristalsis at the UVJ leads to obstruction and upstream dilatation ** '''Secondary''' to bladder pathologic processes, such as neurogenic bladder dysfunction, bladder outlet obstruction, and/or infection * '''Subclassified based on cause (4):''' *# '''Obstructed''' *# '''Refluxing''' *# '''Non-obstructed non-refluxing''' *# '''Refluxing with obstruction''' === Management === * The goal is to prevent renal functional deterioration with either conservative or surgical treatment * '''Conservative''' ** '''> 90% of antenatally detected non-refluxing, non-obstructing megaureters will improve with conservative management within the first few years of life''' ** '''Patients with ureteral diameters > 10 mm were more prone to complications''' * '''Surgery''' ** '''Indications for surgery of POM (5):''' **# '''Symptoms''' **# '''Infections''' (recurring UTIs) **# '''Increasing hydronephrosis/hydroureter''' **# '''< 40% differential renal function''' **# '''≥ 5% decrease in differential renal function of on sequential “comparable” nuclear functional studies''' **#* '''The T 1/2, or Lasix washout time, especially in neonatal megaureters is not a reliable indicator of obstruction''' **#** Washout curves in neonates and infants can be affected by many factors other than restriction of flow. **#** A normal creatinine and symmetric renal function support initial observation in a child ** '''Options (3):''' **# '''Decompression''' **#* '''Indications for prompt decompression:''' **#*# '''Neonate with a megaureter and sepsis''' **#*# Ipsilateral reduced function (< 35% in a neonate) **#*# Marked or increasing hydroureteronephrosis **#* '''Options (2):''' **#*# '''Distal cutaneous ureterostomy (preferred)''' **#*# Nephrostomy tube **#*#* Nephrostomy tubes are difficult to keep in place **# '''Endoscopic''' **#* '''Endoscopic dilatation and stenting of the UVJ in POM is an alternative''' that is less invasive than formal open or laparoscopic surgical intervention, with short- to medium-term success rates ≈70% **# '''Surgical repair''' **#* '''Excision and tapered re-implant''' **#** The stenotic distal part of the ureter is excised **#** The megaureter is straightened and then tapered to facilitate reimplantation in a nonrefluxing fashion with '''adequate ratio of length to diameter of 5:1 to improve coaptation of the ureteral lumen''', whereby effective peristalsis and urine transportation are achieved **#*** '''Ureteral tailoring is usually necessary''' to achieve the proper length-to-diameter ratio required of successful reimplants. Especially in small children, the reimplant can be otherwise impossible. **#*** '''Folding techniques for ureteral tailoring are not applicable in ureters >1.75 cm in diameter.''' **#*** The most serious complication to ureteral tailoring is compromise of the distal vasculature of the ureter with subsequent fibrosis. **#**** Fibrosis can lead to recurrent obstruction and require a redo. However, when performed with care, the risk of vascular compromise should be minimal **#** Most surgeons advocate temporary postoperative stenting **#* '''Complications: obstruction, vesicoureteric reflux, and persistent dilatation''' **#* A concomitant reimplantation and dismembered pyeloplasty should be discouraged, as the ureteral blood supply may be compromised.
Summary:
Please note that all contributions to UrologySchool.com may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
UrologySchool.com:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Page
Discussion
English
Views
Read
Edit
Edit source
View history
More
Search
Navigation
Main page
Clinical Tools
Guidelines
Chapters
Landmark Studies
Videos
Contribute
For Patients & Families
MediaWiki
Recent changes
Random page
Help about MediaWiki
Tools
What links here
Related changes
Special pages
Page information